Bacteria

Assessment of COVID-19's Effect on Sanitizer Market 2020-2024 | Evolving Opportunities with 3M Co. and Godrej Consumer Products Ltd. | Technavio

Thursday, July 2, 2020 - 7:00pm

In addition, the introduction of new products is anticipated to boost the growth of the sanitizer market.

Key Points: 
  • In addition, the introduction of new products is anticipated to boost the growth of the sanitizer market.
  • Hand sanitizer contains at least 60% of alcohol, which kills most kinds of bacteria, including antibiotic-resistant bacteria and tuberculosis bacteria.
  • Godrej Consumer Products Ltd. operates its business through segments such as India, Indonesia, Africa (Including Strength of Nature), and Others.
  • Sanitizer Market Product Outlook (Revenue, USD Billion, 2020-2024)
    Sanitizer Market Geography Outlook (Revenue, USD Billion, 2020-2024)

Crestone, Inc. Secures NIH Funding for Development Through Phase 1 of Novel Antibiotic Candidate CRS0540, A Novel Inhibitor of DNA Replication in Gram-positive Pathogens

Wednesday, July 1, 2020 - 1:00pm

Funding for these studies will be provided entirely by NIHs National Institute of Allergy and Infectious Diseases (NIAID) under Contract No.

Key Points: 
  • Funding for these studies will be provided entirely by NIHs National Institute of Allergy and Infectious Diseases (NIAID) under Contract No.
  • 75N93020C00020 for a total of up to $18.2 million including the base period and subsequent option periods.
  • CRS0540 derives from a series of thiadiazole urea compounds that exhibit potent inhibition of PolC, the catalytic subunit of the replicative DNA polymerase in Gram-positive bacteria.
  • As a novel mechanism of action agent, CRS0540 has shown activity against all clinically relevant antibiotic-resistant Gram-positive pathogens.

Bryant Scientist Christopher Reid secures University's first independent grant from the National Science Foundation

Tuesday, June 30, 2020 - 11:26pm

SMITHFIELD, R.I., June 30, 2020 /PRNewswire/ --Bryant University announced that the National Science Foundation Division of Chemistry has awarded Christopher Reid, Ph.D ., Associate Professor of Science and Technology, a three-year, $296,275 chemical biology grant to study bacterial cell wall metabolism.

Key Points: 
  • SMITHFIELD, R.I., June 30, 2020 /PRNewswire/ --Bryant University announced that the National Science Foundation Division of Chemistry has awarded Christopher Reid, Ph.D ., Associate Professor of Science and Technology, a three-year, $296,275 chemical biology grant to study bacterial cell wall metabolism.
  • This is Bryant's first independent grant secured from the National Science Foundation (NSF), and it enables Professor Reid to develop chemical tools to study how the cell wall is disassembled to allow for growth of bacteria.
  • The grant will provide an opportunity forundergraduate students and post-baccalaureate fellows to acquire multi-disciplinary training at the interface of chemistry and biology.
  • Several Bryant University undergraduate students helped lay the foundation for the grant and will support Professor Reid to generate and analyze the data that arise from the research.

Outlook into the Hand Wash Global Industry to 2026 - Key Drivers and Restraints - ResearchAndMarkets.com

Monday, June 29, 2020 - 2:29pm

The "Global Hand Wash Market By Distribution Channels, By End User, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Hand Wash Market By Distribution Channels, By End User, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • The Global Hand wash Market size is expected to reach $11.9 billion by 2026, rising at a market growth of 7.1% CAGR during the forecast period.
  • Liquid hand wash is an antibacterial liquid that contains an active substance used to inhibit, destroy, or render the active bacteria on hands harmless.
  • Liquid hand wash is a multi-million-dollar industry, with continuous market opportunities due to advances in technology and research and development that have resulted in new offerings in the form of organic hand wash and sensitive skin hand wash, among others.

C-Bond Systems Launches New MB-10 Tablets Sales Campaign for Use Against Human Coronavirus SARS-CoV-2 in the Transportation Sector

Monday, June 29, 2020 - 1:31pm

MB-10 Tablets (EPA Reg No.70060-19-46269) are registered as a broad spectrum hospital disinfectant that is effective against a wide range of bacteria and viruses.

Key Points: 
  • MB-10 Tablets (EPA Reg No.70060-19-46269) are registered as a broad spectrum hospital disinfectant that is effective against a wide range of bacteria and viruses.
  • C-Bond is focusing its sales of MB-10 Tablets on the transportation sector, including vehicle fleets, taxis, rental car companies and more where the company maintains exclusive nationwide distribution rights.
  • Easy to apply using a commercially available sprayer, MB-10 effectively disinfects a vehicle's interior in minutes, including the HVAC system.
  • C-Bond sells MB-10 Tablets under an exclusive, nationwide distribution agreement with Quip Laboratories, Inc. for the domestic transportation sector.

Biocodex Microbiota Foundation Announces Open Call for 2020 US Research Grant Applications

Friday, June 26, 2020 - 12:00pm

BEDMINSTER, N.J., June 26, 2020 /PRNewswire/ -- The Biocodex Microbiota Foundation , an organization founded by Biocodex and committed to inspiring scientific projects that investigate the implication of microbiota in human health, has announced the open call for applications for its annual US research grant, now in its fourth year.

Key Points: 
  • BEDMINSTER, N.J., June 26, 2020 /PRNewswire/ -- The Biocodex Microbiota Foundation , an organization founded by Biocodex and committed to inspiring scientific projects that investigate the implication of microbiota in human health, has announced the open call for applications for its annual US research grant, now in its fourth year.
  • This will be the fourth consecutive year of the Biocodex Microbiota Foundation US grant program.
  • The Biocodex Microbiota Foundation's annual call for grant applications is part of a multi-year research initiative to understand the interaction between microbiota and different pathologies.
  • To learn more information about Biocodex Microbiota Foundation and the 2020 US grant program click here.

Nalco Water Launches Innovative Rapid Bio Intelligence Aerobic Bacteria Test Kit for Cooling Water Management

Thursday, June 25, 2020 - 1:30pm

To help ensure optimal performance, Nalco Water, an Ecolab company, has introduced Rapid Bio Intelligence, a total aerobic bacteria test kit that radically simplifies water chemistry testing and compliance for cooling water systems.

Key Points: 
  • To help ensure optimal performance, Nalco Water, an Ecolab company, has introduced Rapid Bio Intelligence, a total aerobic bacteria test kit that radically simplifies water chemistry testing and compliance for cooling water systems.
  • Nalco Waters Rapid Bio Intelligence is a mobile app-driven test kit to monitor cooling water quality with quick and reliable results.
  • The Rapid Bio Intelligence solution consists of three components:
    Test kit determines the total amount of bacteria present in a water sample, in as little as 15 minutes*.
  • www.ecolab.com
    * The Rapid Bio Intelligence test is not strain-specific and does not measure Legionella bacteria.

Biosenta Announces its First Sale of Product “True” in Canada

Tuesday, June 23, 2020 - 7:24pm

TORONTO, June 23, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (Biosenta or the Company) listed on the CNSX (CNSX:ZRO) is pleased to announce it is launching its disinfectant product called True in Canada.

Key Points: 
  • TORONTO, June 23, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (Biosenta or the Company) listed on the CNSX (CNSX:ZRO) is pleased to announce it is launching its disinfectant product called True in Canada.
  • Biosenta has formed a team called Synergy9 that will look after all the branding, marketing, logistics, and further research and development of our product.
  • True has been approved by Health Canada as clinically proven to kill many different types of Viruses, Bacteria and Fungi.
  • Biosenta Inc. develops and manufactures a range of chemical compounds for household and industrial applications using advanced encapsulated nanotechnology.

Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines

Monday, June 22, 2020 - 1:00pm

The results of the descriptive Phase 2 infant study with 20vPnC (NCT03512288) have been submitted for presentation at ID Week 2020.

Key Points: 
  • The results of the descriptive Phase 2 infant study with 20vPnC (NCT03512288) have been submitted for presentation at ID Week 2020.
  • The Phase 3 trial will enroll approximately 2,413 adolescents and young adults (10 through 25 years of age) from the United States and Europe.
  • Initiation of the Phase 3 trial is based on positive results from a proof-of-concept study (NCT03135834) in 543 adolescents and young adults.
  • Lancet 2017 Sep 2; 390(10098): 946958: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592248/
    12 Poland GA. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.

Immuron Partners with CSIRO to produce a new oral therapeutic for clinical evaluation by the US Department of Defense

Friday, June 19, 2020 - 11:00am

Immuron has now executed a research agreement with Australias national science agency, CSIRO.

Key Points: 
  • Immuron has now executed a research agreement with Australias national science agency, CSIRO.
  • to produce the new therapeutic against Campylobacter and Entero-Toxigenic Escherichia coli (ETEC) for clinical evaluation by the US Department of Defense.
  • Under the terms of the research agreement CSIRO has been engaged to produce a hyper-immune bovine colostrum product using vaccines developed by the NMRC.
  • The work will be conducted at the Department of Agriculture and Water Resources Biosecurity Approved Arrangement facilities located in Armidale NSW.